Cardisure flavoured 5 mg Tablets For dogs

Maa: Irlanti

Kieli: englanti

Lähde: HPRA (Health Products Regulatory Authority)

Osta se nyt

Valmisteyhteenveto Valmisteyhteenveto (SPC)
12-06-2017
DSU DSU (DSU)
23-06-2022

Aktiivinen ainesosa:

Pimobendan

Saatavilla:

Eurovet Animal Health B.V.

ATC-koodi:

QC01CE90

INN (Kansainvälinen yleisnimi):

Pimobendan

Annos:

5 mg/tablet

Lääkemuoto:

Tablet

Prescription tyyppi:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapeuttinen ryhmä:

Dogs

Terapeuttinen alue:

pimobendan

Käyttöaiheet:

Cardiovascular

Valtuutuksen tilan:

Authorised

Valtuutus päivämäärä:

2011-07-22

Valmisteyhteenveto

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Cardisure flavoured 5 mg Tablets For dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 tablet contains:
ACTIVE SUBSTANCE:
Pimobendan
5 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet.
Light brown, round tablets, scored on one side and plain on the other
side.
The tablets can be divided into 4 equal parts.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of canine congestive heart failure originating from
valvular insufficiency (mitral and/or tricuspid
regurgitation) or dilated cardiomyopathy.
4.3 CONTRAINDICATIONS
Do not use in cases of hypertrophic cardiomyopathies or clinical
conditions where an augmentation of cardiac output is
not possible for functional or anatomical reasons (e.g. aortic
stenosis).
See also section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The product should be administered on an empty stomach at least one
hour before meals, as absorption is reduced when
given with feed.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_8_
_/_
_0_
_7_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_2_
_2_
_5_
_6_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
The product is flavoured. To avoid accidental ingestion the tablets
should be stored out of reach of dogs.
An_ in vitro_ study in rat tis
                                
                                Lue koko asiakirja
                                
                            

Etsi tähän tuotteeseen liittyviä ilmoituksia